Articles from SK Capital Partners

Spectrum Vascular (“Spectrum” or the “Company”), a provider of vascular access and medication management products designed to reduce health care-acquired infections, announced today a strategic investment by an affiliate of New York-based private investment firm SK Capital Partners (“SK Capital”).

Deltech Holdings, LLC (“Deltech”), a leading producer of high-performance aromatic monomers, specialized crystal polystyrene, and downstream acrylic resins for the coatings, composites, construction, and other end markets, will be assuming the production of Divinylbenzene (“DVB”) from DuPont.

SK Capital Partners (“SK Capital”), a New York-based private investment firm focused on the specialty materials, ingredients, and life sciences sectors, today announced it has signed a definitive agreement to acquire the North America Composites & Fuel Containment (“CFC”) Division of Parker Hannifin Corporation (NYSE: PH).

SK Capital Partners (“SK Capital”), a New York-based private investment firm focused on the specialty materials, ingredients, and life sciences sectors, today announced that its affiliates have completed the acquisition of Milestone Environmental Services, LLC (“Milestone” or the “Company”), a leading environmental services and carbon management company, from Amberjack Capital Partners, L.P.

Lacerta Group (“Lacerta”) announced that on December 21 it acquired substantially all the assets of Portage Plastics Corporation and PPC Investments, LLC (together, “Portage Plastics”), a manufacturer of thermoformed packaging products based in Portage, WI. As part of the transaction, Lacerta has retained over 50 Portage Plastics employees.

SK Capital Partners (“SK Capital”), a New York-based private investment firm focused exclusively on the specialty chemicals, materials and pharmaceuticals sectors, today announced that its affiliates have completed the acquisition of Valtris Specialty Chemicals (“Valtris” or the “Company”), from H.I.G. Capital.

The Heubach Group (“Heubach”, the “Company”), a leading global producer of pigments and SK Capital Partners (“SK Capital”), a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, announced today the completion of the acquisition of Clariant’s Global Colorants Business (“Clariant Pigments”). The combined business will operate under the Heubach brand, creating a global pigment technology and industry leader.

Funds advised by SK Capital Partners (“SK Capital”), a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, today announced the acquisition of a majority shareholding in SEQENS (the “Company”), one of the world’s leading pharmaceutical solutions and specialty ingredients companies. SK Capital is investing alongside several other investors including Bpifrance, the French national investment bank, Nov Santé, Mérieux Equity Partners, Ardian, Eximium and the Company’s management team.

SK Capital Partners, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, announced it is expanding its team with the addition of Kris Radhakrishnan as Director, Financial Excellence.

SK Capital Partners, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, announced today that Jennifer Cattier has joined the firm as General Counsel & Chief Compliance Officer. Ms. Cattier will also lead SK Capital’s Diversity Equity and Inclusion initiatives.

The Heubach Group (“Heubach”), in partnership with SK Capital Partners (“SK Capital”), announced today a definitive agreement to acquire Clariant’s Pigments Business (“Clariant Pigments”). The combined business will operate under the Heubach name, creating a global pigments leader generating more than €900 million in annual sales.